HSV neutralizing antibodies further refinement in preventing neonatal Herpes infection

American Journal of Obstetrics and Gynecology

Volumn 195, Issue 1, 2006, Pages 4-6

  Lindsay, Michael K ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; MATERNAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANTIBODY DETECTION; CESAREAN SECTION; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; EDITORIAL; GENITAL HERPES; HEALTH CARE POLICY; HERPES; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION PREVENTION; INFECTION RISK; NEWBORN INFECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VIRUS CULTURE; VIRUS TRANSMISSION;

ANTIBODY AFFINITY; DISEASE TRANSMISSION, VERTICAL; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 33745280637     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.02.014     Document Type: Editorial

References (12)

1. Zinkernagel R.M. Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med 345 (2001) 1331-1335
2. Hashido M., Inouye S., and Kawana T. Differentiation of primary from nonprimary genital herpes infections by a herpes simplex virus-specific immunoglobulin G avidity assay. J Clin Microbiol 35 (1997) 1766-1768
3. Devash Y., Calvelli T.A., Wood D.G., Reagan K.J., and Rubinstein A. Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. Proc Natl Acad Sci USA 87 (1990) 3345-3349
4. Grangeot-Keros L., Mayaux M.J., Lebon P., Freymuth F., Eugene G., Stricker R., et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis 175 (1997) 944-946
5. Remington J.S., Thulliez P., and Montoya J.G. Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol 42 (2004) 941-945
6. Morrow R.A., Friedrich D., Krantz E., and Wald A. Development and use of a type- specific antibody avidity test based on herpes simplex virus type 2 glycoprotein G. Sex Transm Dis 31 (2004) 508-515
7. Armstrong G.L., Schillinger J., Markowitz L., Nahmias A.J., Johnson R.E., McQuillan G.M., et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol 153 (2001) 912-920
8. Brown Z., Wald A., Morrow R.A., Selke S., Zeh J., and Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289 (2003) 203-209
9. Brown E.L., Morrow R., Krantz E.M., Arvin A.M., Prober C.G., Yasukawa L.L., et al. Maternal herpes simplex virus antibody avidity and risk of neonatal herpes. Am J Obstet Gynecol 195 (2006) 115-120
10. American College of Obstetrician and Gynecologists practice bulletin: management of herpes in pregnancy. Number 8 (1999), American College of Obstetrician and Gynecologists, Washington DC
11. Baker D., Brown Z., Hollier L.M., Wendel Jr. G.D., Hulme L., Griffiths D.A., et al. Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy. Am J Obstet Gynecol 191 (2004) 2074-2084
12. Baker D.A. Risk factors for herpes simplex virus transmission to pregnant women: a couples study. Am J Obstet Gynecol 193 (2006) 1887-1888